KP Tissue Inc. (TSE:KPT - Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$8.44 and traded as high as C$8.52. KP Tissue shares last traded at C$8.42, with a volume of 20,145 shares traded.
Wall Street Analyst Weigh In
Separately, TD Securities boosted their price objective on shares of KP Tissue from C$8.50 to C$9.00 and gave the company a "hold" rating in a research report on Wednesday, August 14th.
View Our Latest Research Report on KPT
KP Tissue Stock Performance
The company has a market capitalization of C$82.55 million, a PE ratio of 14.07, a P/E/G ratio of -0.88 and a beta of 0.37. The stock has a 50 day moving average price of C$8.47 and a two-hundred day moving average price of C$8.44.
KP Tissue (TSE:KPT - Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The company reported C$0.12 earnings per share for the quarter, missing the consensus estimate of C$0.22 by C($0.10). The company had revenue of C$509.80 million for the quarter, compared to analysts' expectations of C$487.50 million. Sell-side analysts predict that KP Tissue Inc. will post 0.4398964 earnings per share for the current year.
KP Tissue Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 15th will be given a $0.18 dividend. The ex-dividend date of this dividend is Friday, September 27th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 8.70%. KP Tissue's dividend payout ratio is currently 120.00%.
About KP Tissue
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
See Also
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.